Morris, Z. S., Wahl, R. L., Lutzky, J., Patel, R., Mehr, S., Olszanski, A. J., Menda, Y., Arays, R., Srinivas, S. M., Saigal, K., Osman, M., Puhlmann, M., Keefe, S. M., Yang, W., Hanna, A., Kurup, D., Block, M. S. (2026). A phase I/IIa, first-in-human, multicenter, monotherapy and combination therapy with nivolumab dose-finding study of [ 212 Pb]VMT01 melanocortin-1-receptor–targeted, image-guided, alpha-particle therapy in subjects with previously treated unresectable or metastatic melanoma.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.9525